Valence8 US »

Crinetics Pharmaceuticals In shares owned by Valence8 US

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Valence8 US from 13F filings

Historical chart of Valence8 US investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Valence8 US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Valence8 US

Quarter filed Position value Share count Share price at filing
2024-09-30 $342k 6.7k 51.10

More positions owned by Valence8 US

Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Ishares Tr Msci Uk Etf New (EWU)
Ishares Msci Jpn Etf New (EWJ)
Astrazeneca Sponsored Adr Call Option (AZN)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Amgen Put Option (AMGN)
Soleno Therapeutics (SLNO)
Insmed Com Par $.01 Call Option (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Bristol Myers Squibb (BMY)

View all positions for Valence8 US

Top funds holding Crinetics Pharmaceuticals In

BlackRock
BlackRock
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Group
EcoR1 Capital
State Street Corporation
Jennison Associates
Paradigm Biocapital Advisors
Henderson Group
Point72 Asset Management
Geode Capital Management
Franklin Resources
Cormorant Asset Management
Siren

View all funds holding Crinetics Pharmaceuticals In